Evidence map›Paper›PMID 42635750›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026

Association between systemic conditions and the development of glaucoma in a longitudinal large-scale health examination cohort.

Ryo Asaoka, Kazunobu Sugihara, Hiroshi Murata, Yuri Fujino, Shigeki Muto, Masaki Tanito

Abstract read
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ryo AsaokaDepartment of Ophthalmology, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Chuo-ku Hamamatsu, Shizuoka, Hamamatsu, Japan. tky@umin.ac.jp.
Kazunobu SugiharaDepartment of Ophthalmology, Shimane University Faculty of Medicine, Izumo, Japan.
Hiroshi MurataDepartment of Ophthalmology, Toranomon Hospital, Tokyo, Japan.
Yuri FujinoDepartment of Ophthalmology, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Chuo-ku Hamamatsu, Shizuoka, Hamamatsu, Japan.
Shigeki MutoSeirei Center for Health Promotion and Preventive Medicine, Shizuoka, Hamamatsu, Japan.
Masaki TanitoDepartment of Ophthalmology, Shimane University Faculty of Medicine, Izumo, Japan.

Funding

Japan Glaucoma Scoiety Grantthe Ministry of Education, Culture, Sports, Science, and Technology of Japan 19H01114, 18KK0253, 20K09784 and 20K18337the National Center for Geriatrics and Gerontology (NCGG) Japan The Research Funding for Longevity Sciences
6 · The paper itself

Abstract

purposeThis study aimed to investigate the effect of ocular and systemic factors, including a biomarker for inflammation, on the development of glaucoma.

methodWe followed up 9333 subjects from a health checkup cohort for 8 years, during which intraocular pressure (IOP) measurements and color fundus photographing were conducted at least annually, and systemic examinations (including blood pressures and 21 blood examinations) were measured at baseline. Using these data, significant risk factors for the development of glaucoma during follow-up were identified using the Cox proportional hazards regression model.

resultThe mean age and IOP of the 9333 subjects (6118 men) were 52.2 years and 12.6 mmHg, respectively. Glaucoma was developed in 444 subjects during the follow-up period. Older age, higher IOP, lower alcohol intake, and higher C-reactive protein (CRP) levels were the significant risk factors for developing glaucoma. The significant effect of high CRP levels on the development of glaucoma was observed in whole cohort (both in those aged < 60 and ≧ 60 years old).

conclusionsThe current large-scale longitudinal study indicated that inflammation was a significant risk factor for developing glaucoma in addition to older age and higher IOP. Such a significant influence of inflammation on the development of glaucoma may support a possible vascular or atherosclerotic etiology for the disease.

Indexed as

Health examination cohortIntraocular pressure

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.